Strength and muscle mass development after a resistance-training period at terrestrial and normobaric intermittent hypoxia.

Autor: Benavente C; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain., Padial P; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain., Scott BR; Centre for Healthy Ageing, Murdoch University, Perth, Australia.; PHysical Activity, Sport and Exercise (PHASE) Research Group, School of Allied Health (Exercise Science), Murdoch University, Perth, Australia., Almeida F; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain., Olcina G; Faculty of Sport Sciences, University of Extremadura, Cáceres, Spain., Pérez-Regalado S; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain., Feriche B; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain. mbelen@ugr.es.

Publikováno v: Pflugers Archiv : European journal of physiology [Pflugers Arch] 2024 Aug; Vol. 476 (8), pp. 1221-1233. Date of Electronic Publication: 2024 Jun 25.

Sedas, rasos y damascos en la Casa del Conde de Benavente (C. 1533) = Silks, satins and damask fabrics in the House of the Count of Benavente (C. 1533)

Autor: José Pablo Blanco Carrasco

Publikováno v: Estudios Humanísticos. Historia. :11

Las pautas de consumo de las familias castellanas cambiaron a medida que se consolidaron dos procesos descritos por la historiografía reciente. Por una parte,el aumento del capital disponible. Por otra, la llegada al reino de productos de lujo proce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2246504d9ada2b6e5bf8196a5bc5cb2b
https://doi.org/10.18002/ehh.v0i15.5038

Hypoxia matters: comparison of external and internal training load markers during an 8-week resistance training program in normoxia, normobaric hypoxia and hypobaric hypoxia.

Autor: Rodríguez-Zamora L; School of Health and Medical Sciences, Division of Sport Sciences, Örebro University, Örebro, Sweden. lara.rodriguez-zamora@oru.se., Benavente C; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain., Petrer I; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain., Padial P; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain., Timón R; Faculty of Sport Sciences, University of Extremadura, Cáceres, Spain., Arguelles J; High Performance Center of Sierra Nevada, Spanish Sport Council, Granada, Spain., Feriche B; Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain.

Publikováno v: European journal of applied physiology [Eur J Appl Physiol] 2024 Aug; Vol. 124 (8), pp. 2273-2283. Date of Electronic Publication: 2024 Mar 06.

COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.

Autor: Martínez-López J; Hematology Department, Hospital Universitario 12 de Octubre, imas12 Madrid, Universidad Complutense, CNIO-ISCIII, CIBERONC, 28041 Madrid, Spain., de la Cruz J; imas12 Research Institute, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain., Gil-Manso R; Hematology Department, Hospital Universitario 12 de Octubre, imas12 Madrid, Universidad Complutense, CNIO-ISCIII, CIBERONC, 28041 Madrid, Spain., Yuste VJ; Hematology Department, Hospital Universitario La Paz, 28046 Madrid, Spain., Aspa-Cilleruelo JM; Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, 28805 Madrid, Spain., Escobar CE; Hematology Department, Hospital Universitario de Getafe, 28905 Madrid, Spain., López-Jiménez J; Hematology Department, Hospital Universitario Ramón Y Cajal, 28034 Madrid, Spain., Duarte R; Hematology Department, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain., Yerovi CJ; Hematology Department, Hospital Universitario Severo Ochoa, 28914 Madrid, Spain., Hernández-Rivas JÁ; Hematology Department, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain., Herráez R; Hematology Department, Hospital Universitario Infanta Sofía, 28702 Madrid, Spain., Quiroz-Cervantes K; Hematology Department, Hospital Universitario de Móstoles, 28935 Madrid, Spain., Bustelos-Rodriguez R; Hematology Department, Hospital Universitario del Sureste, 28500 Madrid, Spain., Benavente C; Hematology Department, Hospital Clínico San Carlos, 28040 Madrid, Spain., Martínez Barranco P; Hematology Department, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain., Bastos Oteiro M; Hematology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, 28009 Madrid, Spain., Alegre A; Hematology Department, Hospital Universitario de La Princesa, IIS-HUP, 28006 Madrid, Spain., Pérez-Oteyza J; Hematology Department, Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain., Ruiz E; Hematology Department, Hospital Universitario del Tajo, 28300 Madrid, Spain., Marcheco-Pupo EA; Hematology Department, Hospital Universitario Infanta Cristina, 28981 Madrid, Spain., Cedillo Á; Asociación Madrileña de Hematología y Hemoterapia (AMHH), 28010 Madrid, Spain., de Soto Álvarez T; Hematology Department, Hospital Universitario La Paz, 28046 Madrid, Spain., García Ramirez P; Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, 28805 Madrid, Spain., Alonso Trillo R; Hematology Department, Hospital Universitario de Getafe, 28905 Madrid, Spain., Herrera P; Hematology Department, Hospital Universitario Ramón Y Cajal, 28034 Madrid, Spain., Bengochea Casado ML; Hematology Department, Hospital Universitario Severo Ochoa, 28914 Madrid, Spain., Arroyo Barea A; Hematology Department, Hospital Universitario 12 de Octubre, imas12 Madrid, Universidad Complutense, CNIO-ISCIII, CIBERONC, 28041 Madrid, Spain., Martin De Bustamante JM; Hematology Department, Hospital Universitario La Paz, 28046 Madrid, Spain., Ortiz J; Hematology Department, Hospital Universitario de La Princesa, IIS-HUP, 28006 Madrid, Spain., Calbacho Robles M; Hematology Department, Hospital Universitario 12 de Octubre, imas12 Madrid, Universidad Complutense, CNIO-ISCIII, CIBERONC, 28041 Madrid, Spain., García-Suárez J; Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, 28805 Madrid, Spain.

Publikováno v: Cancers [Cancers (Basel)] 2024 Jan 16; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 16.

Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.

Autor: Martínez-Cuadrón D; Hospital Universitari i Politècnic La Fe, Valencia, Spain; Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid. martinez_davcua@gva.es., Megías-Vericat JE; Servicio de Farmacia, Área del Medicamento. Hospital Universitari i Politècnic La Fe, Valencia., Gil C; Hospital General Universitario de Alicante, Alicante., Bernal T; Hospital Universitario Central de Asturias, Asturias, Instituto Universitario de Oncología del Principado de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, ISPA., Tormo M; Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia., Martínez-Sánchez P; Hospital Universitario 12 de Octubre, Madrid., Rodríguez-Medina C; Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas., Serrano J; Hospital Universitario Reina Sofía-IMIBIC, Córdoba., Herrera P; Hospital Universitario Ramón y Cajal, Madrid., Simón JAP; Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS / CISC), Universidad de Sevilla, Sevilla., Sayas MJ; Hospital Universitario Doctor Peset, Valencia., Bergua J; Hospital San Pedro Alcántara, Cáceres., Lavilla-Rubira E; Hospital Universitario Lucus Augusti, Lugo., Amigo ML; Hospital General Universitario Morales Meseguer, Murcia., Benavente C; Hospital Clínico San Carlos, Madrid., Lorenzo JLL; Hospital Universitario Fundación Jiménez Díaz, Madrid., Pérez-Encinas MM; Hospital Clínico Universitario de Santiago, Santiago de Compostela., Vidriales MB; Hospital Clínico Universitario de Salamanca, Salamanca., Colorado M; Hospital Universitario Marqués de Valdecilla, Santander., De Rueda B; Hospital Universitario Miguel Servet, Zaragoza., García-Boyero R; Hospital General Universitari de Castelló, Castellón., Marini S; Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra., García-Suárez J; Hospital Universitario Príncipe de Asturias, Madrid., López-Pavía M; Hospital General Universitario de Valencia, Valencia., Gómez-Roncero MI; Hospital Universitario de Toledo, Toledo., Noriega V; Complejo Hospitalario Universitario A Coruña, A Coruña., López A; Hospital Arnau de Vilanova, Valencia., Labrador J; Hospital Universitario de Burgos, Burgos., Cabello A; Hospital Universitario Nuestra Señora de Candelaria, Tenerife., Sossa C; FOSCAL, Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Bucaramanga., Algarra L; Hospital General Universitario de Albacete, Albacete., Stevenazzi M; Hospital de Clínicas Dr. Manuel Quintela, Montevideo, Uruguay., Solana-Altabella A; Servicio de Farmacia, Área del Medicamento. Hospital Universitari i Politècnic La Fe, Valencia., Boluda B; Hospital Universitari i Politècnic La Fe, Valencia, Spain; Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia., Montesinos P; Hospital Universitari i Politècnic La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid.

Publikováno v: Haematologica [Haematologica] 2024 Jan 01; Vol. 109 (1), pp. 115-128. Date of Electronic Publication: 2024 Jan 01.